Bart Jan Kullberg Selected Research

Bart Jan Kullberg Research Topics

Disease

35	Infections 02/2022 - 01/2002
19	Candidiasis (Moniliasis) 02/2022 - 01/2002
9	Lyme Disease (Disease, Lyme) 04/2022 - 10/2014
7	Sepsis (Septicemia) 12/2019 - 12/2002
6	Aspergillosis 01/2018 - 10/2004
6	Inflammation (Inflammations) 01/2017 - 01/2002
6	Mycoses (Diseases, Fungus) 01/2011 - 04/2004
5	Candidemia 01/2019 - 08/2004
5	Invasive Fungal Infections 03/2014 - 10/2004
4	Necrosis 02/2022 - 11/2003
4	Fever (Fevers) 07/2019 - 01/2005
4	Abscess 06/2017 - 12/2002
4	Crohn Disease (Crohn's Disease) 04/2008 - 07/2004
3	Invasive Candidiasis 01/2019 - 01/2017
2	Bacteremia 07/2019 - 03/2012
2	Foreign Bodies (Foreign Body) 07/2019 - 03/2012
2	Neutropenia 01/2018 - 01/2017
2	Cryptococcal Meningitis 11/2004 - 10/2004
2	Atherosclerosis 07/2002 - 01/2002
1	Anastomotic Leak 04/2022
1	Critical Illness (Critically Ill) 04/2022
1	Liver Failure 04/2022
1	Bacterial Infections (Bacterial Infection) 04/2022
1	Herpes Simplex 02/2022
1	Herpesviridae Infections (Herpesvirus Infection) 02/2022
1	Drug-Related Side Effects and Adverse Reactions 02/2022
1	Epstein-Barr Virus Infections 02/2022
1	Cytomegalovirus Infections (Inclusion Disease) 02/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2022
1	Cutaneous Candidiasis 02/2022
1	Arthritis (Polyarthritis) 05/2020
1	Endocarditis 07/2019
1	Aspiration Pneumonia 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Deglutition Disorders (Dysphagia) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Cytokine Release Syndrome 01/2018
1	Borrelia Infections 12/2016

Drug/Important Bio-Agent (IBA)

19	CytokinesIBA 01/2018 - 01/2002
11	Anti-Bacterial Agents (Antibiotics)IBA 04/2022 - 10/2014
8	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2008 - 01/2002
7	Interleukin-18 (Interleukin 18)IBA 06/2006 - 04/2002
6	InterleukinsIBA 02/2022 - 04/2002
6	Interferon-gamma (Interferon, gamma)IBA 06/2017 - 12/2002
5	Interleukin-12 (IL 12)IBA 02/2022 - 04/2002
5	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2009 - 05/2002
4	Voriconazole (Vfend)FDA LinkGeneric 01/2019 - 08/2011
4	Interleukin-10 (Interleukin 10)IBA 03/2006 - 07/2004
3	Amphotericin B (Amphotericin)FDA LinkGeneric 01/2014 - 12/2003
3	Pattern Recognition ReceptorsIBA 03/2011 - 08/2008
3	Lipoproteins (Lipoprotein)IBA 01/2009 - 08/2004
2	Biological ProductsIBA 02/2022 - 04/2002
2	Interleukin-17 (Interleukin 17)IBA 02/2022 - 10/2010
2	VaccinesIBA 05/2020 - 01/2010
2	Doxycycline (Periostat)FDA LinkGeneric 01/2019 - 03/2016
2	Clarithromycin (Biaxin)FDA LinkGeneric 01/2019 - 03/2016
2	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2019 - 03/2016
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018 - 05/2006
2	Antifungal AgentsIBA 03/2014 - 12/2003
2	Fluconazole (Zonal)FDA LinkGeneric 08/2011 - 12/2003
2	Biomarkers (Surrogate Marker)IBA 02/2011 - 11/2010
2	AntibodiesIBA 04/2009 - 07/2003
2	Apolipoproteins E (ApoE)IBA 01/2009 - 08/2004
2	LipopolysaccharidesIBA 01/2009 - 04/2008
2	LigandsIBA 04/2008 - 07/2004
2	NucleotidesIBA 04/2008 - 04/2006
2	Toll-Like Receptor 4IBA 03/2006 - 07/2003
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 09/2005 - 12/2003
2	InterferonsIBA 11/2004 - 04/2002
2	Lymphotoxin-alpha (Lymphotoxin)IBA 12/2002 - 01/2002
1	Ustekinumab (CNTO 1275)FDA Link 02/2022
1	Infliximab (Remicade)FDA Link 02/2022
1	secukinumabIBA 02/2022
1	ProteomeIBA 02/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2019
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Caspofungin (Cancidas)FDA Link 01/2019
1	isavuconazoleIBA 01/2019
1	PlatinumIBA 01/2019
1	Complement Receptors (Complement Receptor)IBA 01/2018
1	Peroxidase (Myeloperoxidase)IBA 01/2018
1	CoagulaseIBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	Anidulafungin FDA Link 01/2017
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2017
1	Clindamycin (Cleocin)FDA LinkGeneric 01/2017
1	Lactic Acid (Lactate)FDA LinkGeneric 12/2016
1	Glucose (Dextrose)FDA LinkGeneric 12/2016
1	Immunoglobulin M (IgM)IBA 03/2016

Therapy/Procedure

20	Therapeutics 02/2022 - 04/2003
8	Immunotherapy 01/2018 - 04/2004
2	Aftercare (After-Treatment) 04/2022 - 07/2021
2	Immunomodulation 09/2005 - 12/2003
1	Parenteral Nutrition 04/2022
1	Duration of Therapy 07/2019
1	Chemoradiotherapy 01/2019
1	Drug Therapy (Chemotherapy) 01/2018
1	Debridement 01/2017